Shiga Toxin-Producing Escherichia coli Transmission via Fecal Microbiota Transplant.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 33159210.
- Also identified by DOI 10.1093/cid/ciaa1486.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Fecal microbiota transplantation (FMT) is recommended therapy for multiply recurrent Clostridioides difficile infection. We report adverse events in 7 patients who received FMT from a stool donor who was colonized with Shiga toxin-producing Escherichia coli (STEC). No patients died of FMT-transmitted STEC. Improved screening can likely avoid future transmission.
Medical subject headings
- Clostridioides difficile
- Clostridium Infections
- Escherichia coli Infections
- Microbiota
- Shiga-Toxigenic Escherichia coli